{"id":25994,"date":"2024-02-29T13:11:23","date_gmt":"2024-02-29T18:11:23","guid":{"rendered":"https:\/\/nephcure.org\/?page_id=25994"},"modified":"2025-11-20T15:05:33","modified_gmt":"2025-11-20T20:05:33","slug":"nuestro-impacto","status":"publish","type":"page","link":"https:\/\/nephcure.org\/es\/about\/our-impact\/","title":{"rendered":"Nuestro Impacto"},"content":{"rendered":"
\n
Home<\/a><\/span> \/ About<\/a><\/span> \/ Our Impact<\/span><\/span><\/div>\n\n
\n\n

Our Impact<\/h1>\n\n\n\n

Building a Better World for People with Rare Kidney Disease<\/strong><\/h5>\n\n\n\n


Until just recently, rare kidney disease was full of \u201cunknowns\u201d \u2014 Who\u2019s most at risk? What treatments work best? How do I live with this diagnosis? Our impact lives in finally finding answers to these questions. Since our founding in 2000, NephCure has made enormous progress in advancing research, patient care, and RKD therapies. We\u2019re leading a revolution for rare kidney disease, a reality that wouldn\u2019t be possible without the strength of our community standing behind us.<\/p>\n\n\n

\n\nGive Now<\/a>\n\n<\/div>\n\n
<\/div>\n<\/div>\n<\/section>\n\n
<\/a>\n\n
\"Headline<\/figure>\n\n\n\n

Together, We’ve Transformed Lives.<\/h2>\n\n\n\n

One day in 2000, a group of four patient families, the Antoshes, the Ortons, the Smoklers, and the Stewarts, came together dedicated to making a difference. That moment changed the future of rare kidney disease forever.<\/p>\n\n<\/div>\n\n

<\/a>\n
\n
\n
\n\n

2000<\/h2>\n\n\n\n

At the time of NephCure\u2019s founding, there were zero drugs in research<\/strong> for nephrotic syndrome, FSGS, and other rare kidney diseases, and little understanding of the disease at all.<\/p>\n\n<\/div>\n<\/div><\/div>\n\n

\n
\n\n

Today<\/h2>\n\n\n\n

A little over 25 years later, thanks to our coordinated efforts in fundraising, awareness, and community building, there are now 60+ drugs in clinical trial<\/strong>, creating a new reality for RKD patients everywhere.<\/p>\n\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n

\n
\n
\n
\n\n
\"\"<\/figure>\n\n<\/div><\/div>\n\n
\n\n
\"Headline<\/figure>\n\n\n\n

25 Years of Impact: Advancing Care, Research, and Hope<\/h2>\n\n\n\n

NephCure’s 2025 Impact Report<\/strong><\/h6>\n\n\n\n

Discover how NephCure is accelerating progress for people living with rare kidney disease in our latest Impact Report. This year, more than 60 drug trials<\/strong> are now underway thanks to a community that refused to accept \u201cno answers,\u201d an expert care network of 200+ Specialists<\/strong> is supporting 40,000+ patients and families<\/strong>, and policy breakthroughs<\/strong> are improving diagnosis and care at both state and federal levels. <\/p>\n\n\n\n

See how your support is driving real, tangible change.<\/p>\n\n\n\nLEARN MORE<\/a>\n\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n

\n
\n
\n
\n\n
\"Headline<\/figure>\n\n\n\n

Why We Do What We Do: Hear Joshua\u2019s Story<\/h2>\n\n\n\n
<\/div>\n\n\n\n

Meet Joshua Albright, a happy and seemingly-healthy 17-year-old who had just graduated from high school, and on his way to college. His life changed when he was diagnosed with FSGS, a rare and rapidly progressing kidney disease. His future suddenly seemed uncertain. Fortunately, Joshua was able to enroll in a clinical trial for a new FSGS therapy, a reality made possible by NephCure\u2019s ongoing fight for rare kidney disease research.<\/p>\n\n\n

\n\nMore patient Stories<\/a>\n\n<\/div>\n<\/div><\/div>\n\n
\n\n
\n